Through enhanced pharmacokinetic profiles, once-weekly GLP-1RA injections, notably semaglutide, are becoming increasingly popular in the treatment of T2DM
The relationship between GLP-1 therapy and joint pain relief appears to be multifactorial rather than a direct pharmacological effect on joint tissues
Can I switch medications instead of taking a complete break
Several large clinical trials have demonstrated that GLP-1 receptor agonists can reduce the risk of cardiovascular events, such as heart attacks and strokes, in people with type 2 diabetes who are at high risk for heart disease
Weight loss typically occurs gradually over the following months
Nutritionists and obesity medicine specialists generally acknowledge that compounded semaglutide, when sourced from an FDA-registered compounding pharmacy and prescribed by a licensed provider, may offer a pharmacologically equivalent effect to brand-name formulations, though it is important to note that compounded products have not undergone the same FDA approval process as brand-name drugs
